THISX: T. Rowe Price Health Sciences I

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

THISX T. Rowe Price Health Sciences I


Profile

THISX - Profile

Vitals

  • YTD Return 11.0%
  • 3 Yr Annualized Return 9.0%
  • 5 Yr Annualized Return N/A
  • Net Assets $15.1 B
  • Holdings in Top 10 32.4%

52 WEEK LOW AND HIGH

$90.38
$60.39
$92.64

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.65%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 38.80%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000,000
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return 11.0%
  • 3 Yr Annualized Total Return 9.0%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.11%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    T. Rowe Price Health Sciences Fund
  • Fund Family Name
    T. Rowe Price
  • Inception Date
    Mar 23, 2016
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ziad Bakri

Fund Description

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Fund Company Quick Screens

THISX - Fund Company Quick Screens


Performance

THISX - Performance

Return Ranking - Trailing

Period THISX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.0% -3.8% 17.7% 27.13%
1 Yr 17.0% -0.9% 30.4% 51.59%
3 Yr 9.0%* -11.5% 22.1% 29.09%
5 Yr N/A* -11.6% 12.2% 4.72%
10 Yr N/A* -1.2% 17.1% 1.11%

* Annualized

Return Ranking - Calendar

Period THISX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 5.7% 55.4% 37.07%
2018 -4.7% -25.3% 21.5% 34.55%
2017 19.1% -10.8% 43.9% 41.67%
2016 N/A -31.6% 6.9% N/A
2015 N/A -20.4% 13.8% N/A

Total Return Ranking - Trailing

Period THISX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.0% -3.8% 17.7% 27.13%
1 Yr 17.0% -0.9% 30.4% 51.59%
3 Yr 9.0%* -11.5% 25.2% 39.09%
5 Yr N/A* -11.6% 16.9% 8.49%
10 Yr N/A* -1.2% 19.4% 1.11%

* Annualized

Total Return Ranking - Calendar

Period THISX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 5.7% 55.4% 37.07%
2018 -4.7% -25.3% 22.2% 42.73%
2017 19.1% -10.8% 45.8% 54.63%
2016 N/A -26.4% 8.7% N/A
2015 N/A -16.6% 15.2% N/A

NAV & Total Return History


Holdings

THISX - Holdings

Concentration Analysis

THISX Category Low Category High THISX % Rank
Net Assets 15.1 B 2.28 M 49 B 2.99%
Number of Holdings 153 27 435 8.21%
Net Assets in Top 10 4.42 B 579 K 18.8 B 3.73%
Weighting of Top 10 32.41% 21.5% 76.0% 82.09%

Top 10 Holdings

  1. UnitedHealth Group Inc 5.73%
  2. Vertex Pharmaceuticals Inc 4.45%
  3. Thermo Fisher Scientific Inc 3.86%
  4. Intuitive Surgical Inc 3.52%
  5. Becton, Dickinson and Co 3.02%
  6. Eli Lilly and Co 2.47%
  7. Danaher Corp 2.38%
  8. Merck & Co Inc 2.38%
  9. Regeneron Pharmaceuticals Inc 2.35%
  10. AbbVie Inc 2.24%

Asset Allocation

Weighting Return Low Return High THISX % Rank
Stocks
99.32% 65.31% 100.23% 24.63%
Cash
0.67% -0.23% 34.69% 82.09%
Preferred Stocks
0.00% 0.00% 4.57% 72.39%
Other
0.00% -1.66% 9.19% 73.88%
Convertible Bonds
0.00% 0.00% 0.00% 65.67%
Bonds
0.00% 0.00% 16.54% 67.91%

Stock Sector Breakdown

Weighting Return Low Return High THISX % Rank
Healthcare
99.49% 60.00% 100.00% 60.45%
Basic Materials
0.51% 0.00% 2.52% 8.96%
Utilities
0.00% 0.00% 0.00% 65.67%
Technology
0.00% 0.00% 20.28% 66.42%
Real Estate
0.00% 0.00% 5.63% 68.66%
Industrials
0.00% 0.00% 6.39% 67.16%
Financial Services
0.00% 0.00% 1.55% 73.13%
Energy
0.00% 0.00% 0.00% 65.67%
Communication Services
0.00% 0.00% 2.60% 65.67%
Consumer Defense
0.00% 0.00% 36.48% 67.91%
Consumer Cyclical
0.00% 0.00% 1.06% 65.67%

Stock Geographic Breakdown

Weighting Return Low Return High THISX % Rank
US
86.41% 53.12% 99.43% 21.64%
Non US
12.91% 0.00% 45.40% 74.63%

Expenses

THISX - Expenses

Operational Fees

THISX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.65% 0.10% 25.14% 95.45%
Management Fee 0.64% 0.00% 1.25% 41.79%
12b-1 Fee N/A 0.00% 1.00% 5.56%
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

THISX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

THISX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

THISX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 38.80% 0.70% 248.00% 53.08%

Distributions

THISX - Distributions

Dividend Yield Analysis

THISX Category Low Category High THISX % Rank
Dividend Yield 0.00% 0.00% 0.06% 65.67%

Dividend Distribution Analysis

THISX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

THISX Category Low Category High THISX % Rank
Net Income Ratio 0.11% -2.53% 2.12% 36.84%

Capital Gain Distribution Analysis

THISX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

THISX - Fund Manager Analysis

Managers

Ziad Bakri


Start Date

Tenure

Tenure Rank

Apr 01, 2016

4.33

4.3%

Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment banking analyst positions in other investment firms

Tenure Analysis

Category Low Category High Category Average Category Mode
0.16 22.89 8.72 20.26